Bridging Thoracic Endovascular Aneurysm Repair for a Late Rupture Following Aortic Coarctation Angioplasty by Oliveira, N et al.
Original Article
Bridging thoracic endovascular aneurysm repair for a late
rupture following aortic coarctation angioplasty
Nelson F. G. Oliveira,1,2 João A. Castro,1 José D. Martins,3 Anita Quintas,1 Sérgio Laranjo,3 Hugo Valentim,1
Fátima Pinto,1 Luís M. Capitão1
1Department of Angiology and Vascular Surgery, Santa Marta Hospital, Lisbon; 2Department of Angiology and Vascular
Surgery, Divino Espírito Santo Hospital, Ponta Delgada; 3Department of Pediatric Cardiology, Santa Marta Hospital,
Lisbon, Portugal
Abstract Introduction: Thoracic endovascular aneurysm repair has been employed to treat late complications after
aortic coarctation correction. However, its use in children has seldomly been reported. Case report:We present the
case of a 15-year-old child who presented with a ruptured aneurysm of the descending aorta complicated later by
an aortic-oesophageal ﬁstula following aortic coarctation stenting that was managed with multiple bridging
endovascular interventions until a deﬁnitive repair was performed. Conclusion: Thoracic endovascular aneurysm
repair may be used successfully as a bridging intervention to a deﬁnitive repair in children with life-threatening
aortic complications following aortic coarctation repair.
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AORTIC COARCTATION OCCURS IN UP TO FOURin 10,000 newborns, representing 5–8% ofall congenital cardiac abnormalities.1 Percuta-
neous methods have emerged as an alternative to
open surgery for the treatment of aortic coarctation in
selected patients.2 Among the possible complications
following intervention is late aneurysm formation.3,4
To minimise the risk of this event as well as the
risk of aortic rupture or restenosis, primary stenting
is preferred over balloon angioplasty for primary aortic
coarctation.5,6 Particularly, covered stents have
been favoured in patients with complex anatomy or
complications following previous percutaneous
intervention.7,8
We present the case of an adolescent who presented a
late thoracic aortic aneurysm rupture following aortic
angioplasty who was managed initially by endovascular
means.
Case report
We report the case of a 15-year-old boy upon whom an
aortic angioplasty with a covered stent (AdvantaTM V12
Atrium covered stent, 12×29mm) had been
performed 2 years earlier for an aortic coarctation with a
peak-to-peak systolic gradient of 40mmHg. His
past medical story was notorious for systemic
hypertension, and on the workup a bicuspid aortic valve
was identiﬁed. A year after the ﬁrst intervention, a
signiﬁcant restenosis was diagnosed (baseline peak-
to-peak systolic gradient of 20mmHg) leading to an
additional angioplasty and covered stent implantation
(Advanta V12 Atrium 14×29mm).
Fifteen months after the second intervention, the
patient presented to the emergency department with
complaints of fatigue, dyspnoea, and left thoracic
pain. These symptoms had progressively worsened
over the previous 3 weeks. A thoracic computerised
tomography (CT) angiography was performed after
detection of an enlarged mediastinum and a collapsed
left lung on a chest radiograph, conﬁrming an intact
thoracic aortic aneurysm with 5.8 cm of maximum
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diameter (Fig 1). No signs of rupture were reported at
this point. The patient was then transferred for
consultation by his assistant paediatric cardiologist.
While under observation, the patient presented a
sudden stab-like thoracic pain, which radiated to
the interscapular area and became hypotensive.
On the laboratorial workup upon arrival, a decrease in
his haemoglobin level was already present (from 11.4
to 9.0 g/dl) when compared with the previous
workup from his local emergency department. This
patient was immediately discussed among
the Departments of Vascular Surgery, Cardiothoracic
Surgery, and Paediatric Cardiology. A thoracic
endovascular aneurysm repair was preferred as
an initial bridging therapy as he had become
hypotensive and a conventional aneurysm repair
was deemed excessively risky. The patient was
immediately transferred to the operating theatre
where the thoracic aneurysm rupture was conﬁrmed
on angiography. To match device sizing to the
patient’s morphology, two components were
required. A ﬁrst 16–20 mm iliac extension of an
abdominal aortic endograft (Endurant®, Medtronic,
Santa Rosa, California, United States of America) was
deployed proximally, sealing in Ishimaru’s zone 3,
and was extended distally with a 23 mm iliac limb
(Excluder, Gore & Associates, Flagstaff, Arizona,
United States of America). (Fig 2). The immediate
postoperative period was uneventful. A postoperative
CT angiography performed 1 week after the
intervention conﬁrmed the complete exclusion
of the aneurysm without any endoleaks. During
hospitalisation the patient remained haemodynami-
cally stable and the left lung progressively
re-expanded. The patient was discharged home after
2 weeks of hospitalisation awaiting a deﬁnitive repair.
During an outpatient visit for a scheduled trans-
thoracic echocardiography 1 week after discharge, the
patient presented an abundant haematemesis followed
by syncope and shock (systolic pressure of 54mmHg).
An aortic-oesophageal ﬁstula was assumed and the
patient was rushed to the operating room where the
ﬁstula was conﬁrmed as well as a type 1A endoleak.
A 21mm thoracic stentgraft (Gore TAG) was
deployed, sealing proximally, excluding the left
subclavian artery. Owing to unintentional partial
coverage, however, a left common carotid artery bailout
stent was required (Fig 3), which was achieved from the
femoral access. An intraoperative haemoglobin
concentration of 5.4 g/dl was conﬁrmed and the patient
underwent intensive transfusional support. The ﬁrst
postoperative CT angiography conﬁrmed the successful
exclusion of the aortic-oesophageal ﬁstula, without any
detectable endoleaks. The patient was kept on total
parenteral nutrition and empiric antibiotherapy with
meropenem and vancomycin. A few days later, a fever
(38.0°C) developed despite persistently negative blood
cultures. On a second postoperative CT the oesophageal
defect was again identiﬁed and endograft infection was
assumed, although clear signs of infection were not
reported. At this time, an open conversion was deemed
unavoidable and the patient was transferred to a
specialised cardiac surgical centre.
At this centre, the patient was initially
treated with a homograft aortic interposition under
circulatory arrest. The left subclavian artery
was revascularised at this intervention and all
Figure 1.
CT angiography reconstruction demonstrating the ruptured
descending aorta aneurysm.
Figure 2.
Three-dimensional CT angiography reconstruction following
thoracic endovascular aneurysm repair demonstrating exclusion of
the aneurysm, without endoleaks.
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endoluminal devices were removed. The oesophageal
ﬁstula was excluded with primary closure and
a latissimus dorsi ﬂap was tailored to wrap around
the homograft, covering the ﬁstula. However, on
the 25th postoperative day, following the drainage
of an infected haemothorax, the patient presented
haematemesis, which was treated with endoscopic
oesophageal clipping. On the 46th postoperative
day, the patient presented a massive haemothorax
due to homograft disruption. A thoracic endovascular
aneurysm repair was once again performed with
the patient severely shocked, as a bridge to a second
open surgery, which would be performed 22 days
later. The homograft and stentgraft were explanted;
the distal thoracic aortic stump was ligated, as
well as the left subclavian and common carotid
arteries, and an extra-anatomic ascending aorta to
a descending aorta bypass was performed. During the
early postoperative period, compression of the
left bronchus and pulmonary atelectasis required
elective intubation, but was otherwise uneventful.
An oesophagography conﬁrmed the complete
healing of the ﬁstula, and progressively oral intake
was reinstated.
After an overall period of ~5 months of
hospitalisation since clinical presentation, the
patient was discharged home. Antibiotherapy
was continued for another month with Moxiﬂoxacin
and Linezolid. After 6 months of follow-up, no
signs of relapse of the aortic-oesophageal ﬁstula have
been identiﬁed.
Discussion
Thoracic aortic aneurysm rupture is a highly fatal
condition with a reported mortality rate of 97–100%.9
Owing to its reduced perioperative morbidity and
mortality when compared with open surgery, thoracic
endovascular aneurysm repair has emerged as an alter-
native in both elective and emergent treatment of late
aneurysms following aortic coarctation surgery in
adults.10,11 Besides being controversial, however, thor-
acic endovascular aneurysm repair in children is chal-
lenging. Small access vessels, unavailability of approved
endografts, and largely unknown long-term outcomes
have precluded thoracic endovascular aneurysm repair
in this group of patients.12 Moreover, patients with
aortic coarctation may have a hypoplastic isthmus and
associated severe aortic angulation at this level, thus
requiring additional consideration during endovascular
repair planning.
Wu et al reported the case of an acute aortic rup-
ture immediately after aortoplasty in a 9-year-old
child with Turner syndrome. In this case, an iliac
limb graft (Cook, Bloomington, Indiana, United
States of America) was deployed with resource to
open sternotomy because of access vessel restrains at
the iliac and femoral level.13 In our patient, a femoral
access was possible. Device selection took into
account the morphological restrains of the hypoplas-
tic isthmic aorta. In this case, excessive oversizing was
avoided to reduce the risk of endograft collapse.14,15
Although used in an off-label indication, the device
initially excluded the ruptured aneurysm. Never-
theless, we hypothesise that, because of the inability
of this non-dedicated device to cope with the acute
angulation at the proximal landing zone and lack of
active ﬁxation, a proximal “birdbeak” developed,
which ultimately lead to device migration, proximal
type 1 endoleak, aneurysm repressurisation, and sec-
ondary rupture. Decision not to deploy the endograft
initially proximal to the left subclavian artery was
based upon the temporary intention of this repair and
the risk of stroke and spinal cord ischaemia in a
haemodynamically unstable patient.16–18
Our patient subsequently developed an aortic-
oesophageal ﬁstula, which is a well-known and feared
complication that occurs in up to 2% of patients
following thoracic endovascular aneurysm repair.19,20
In this clinical scenario, thoracic endovascular aneurysm
repair has also been reported to be effective in preventing
immediate exsanguination.21 However, the results in
the mid-term are poor, and therefore this method has
been regarded only as a bridging intervention rather
than a deﬁnitive treatment.21,22
In our patient, immediate exsanguination due
to thoracic aortic aneurysm rupture, followed by a
secondary aortic-oesophageal ﬁstula and ﬁnally by an
Figure 3.
Three-dimensional CT angiography reconstruction of the
postoperative control following re-do thoracic endovascular aneurysm
repair, with bailout left carotid stenting.
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aortic homograft disruption, was prevented with
thoracic endovascular aneurysm repair, thus allowing
patient stabilisation and ultimately deﬁnitive
correction.
Conclusion
In children with life-threatening aortic complications
such as a ruptured thoracic aneurysm or an aortic-
oesophageal ﬁstula, thoracic endovascular aneurysm
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